Stay updated on ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial
Sign up to get notified when there's something new on the ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial page.

Latest updates to the ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to include the COVID-19 Disease and the new version of the trial, Revision: v2.15.0, while significant details about the trial's design and inclusion criteria have been removed.SummaryDifference32%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 24, 2025.SummaryDifference0.4%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous estimated dates and version.SummaryDifference0.4%
- Check73 days agoChange DetectedThe webpage has been updated to include new results and endpoints related to the ABNCoV2 vaccine trial, specifically focusing on immunogenicity, safety, and tolerability, while removing outdated information about previous results and trial comparisons.SummaryDifference27%
- Check88 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABNCoV2 Vaccine in Previous SARS-CoV-2 Vaccinated Adults Clinical Trial page.